Skip to main content

Month: March 2026

Passage Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Recent Business Highlights

Enrolled first three FTD-GRN patients in Cohort 3 of ongoing upliFT-D study Treated first FTD-C9orf72 patient with Dose 2 PBFT02 in Cohort 4 of upliFT-D study On track to report updated interim safety and biomarker data from upliFT-D and obtain regulatory feedback on FTD-GRN registrational trial design in 1H 2026 Advancing differentiated preclinical program for Huntington’s with clinical candidate selection expected in 2H 2026 Cash runway through 1Q 2027 PHILADELPHIA, March 03, 2026 (GLOBE NEWSWIRE) — Passage Bio, Inc. (Nasdaq: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today reported financial results for the fourth quarter and year ended December 31, 2025, and provided recent business highlights. “We are proud of the progress made in 2025 as we...

Continue reading

Sportradar Reports Fourth Quarter and Full Year 2025 Financial Results, and Announces Significant Expansion in Share Repurchase Plan to $1 Billion

Full Year 2025 HighlightsRevenue increased 17% to a record €1,290 million Generated profit for the period of €100 million, 7.8% as a percentage of revenue Adjusted EBITDA1 increased 33% to a record €297 million and Adjusted EBITDA margin1 expanded 291 basis points to 23.0% Generated net cash from operating activities of €403 million and record Free cash flow1 of €167 million Repurchased $91 million of shares and announced significant increase in share repurchase plan bringing total authorization from $300 million to $1 billion Achieved a Customer Net Retention Rate1 of 109% Completed the acquisition of IMG ARENA and its global sports betting rights portfolioFourth Quarter 2025 HighlightsRevenue increased 20% to €369 million Generated profit for the period of €4 million, 1.2% as a percentage of revenue Adjusted EBITDA increased 48%...

Continue reading

Advantage Solutions Reports Fourth Quarter and Full Year 2025 Results

  Strong cash flow performance resulted in ending the quarter with $241 million of cash, up $40 million sequentially    Completion of non-core divestitures, planned debt refinancing and upcoming reverse stock split    Expect flat to up low-single digit revenue growth in 2026, Adjusted EBITDA flat to down mid-single digits    ST. LOUIS, March 03, 2026 (GLOBE NEWSWIRE) — Advantage Solutions Inc. (NASDAQ: ADV) (“Advantage,” “Advantage Solutions,” the “Company,” “we,” or “our”), a leading business solutions provider to consumer goods manufacturers and retailers, today reported financial results for the three and twelve months ended December 31, 2025. Unless otherwise noted, results presented in this release are from continuing operations, and comparisons are on a prior year basis. Revenues for the three months ended December 31, 2025...

Continue reading

Gilat to Showcase Advanced Defense Connectivity Solutions at Satellite 2026

Gilat Defense empowers defense forces with integrated communications solutions built for mission‑critical operations PETAH TIKVA, Israel, March 03, 2026 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, announced today that its defense division, Gilat Defense, will showcase a comprehensive suite of advanced defense‑grade connectivity technologies at Satellite 2026, taking place March 23-26 in Washington, D.C. At the show, Gilat Defense will showcase proven solutions offering multi‑domain and multi‑orbit flexibility, as well as integrated commercial technologies to enhance defense capabilities. Visitors to the Gilat Defense booth will experience hands‑on demonstrations and interactive displays across a wide range of defense...

Continue reading

Medline Inc. announces launch of secondary offering of Class A common stock

NORTHFIELD, Ill., March 03, 2026 (GLOBE NEWSWIRE) — Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the “Selling Stockholders”) have commenced an underwritten public offering of 75,000,000 shares of Medline’s Class A common stock pursuant to a registration statement filed with the Securities and Exchange Commission (the “SEC”). Additionally, the Selling Stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 11,250,000 shares of Medline’s Class A common stock. Medline is not selling any shares of Class A common stock in the offering and will not receive any of the proceeds from the sale. Goldman Sachs...

Continue reading

AutoZone 2nd Quarter Total Company Same Store Sales Increase 3.3%; Domestic Same Store Sales Increase 3.4%; EPS of $27.63

MEMPHIS, Tenn., March 03, 2026 (GLOBE NEWSWIRE) — AutoZone, Inc. (NYSE: AZO) today reported net sales of $4.3 billion for its second quarter (12 weeks) ended February 14, 2026, an increase of 8.1% from the second quarter of fiscal 2025 (12 weeks). Same store sales, or sales for our domestic and international stores open at least one year, are as follows:      Constant Currency       Constant Currency  12 Weeks   12 Weeks*   24 Weeks   24 Weeks*               Domestic 3.4 %   3.4 %   4.2 %   4.2 %International 17.1 %   2.5 %   14.2 %   3.1 %Total Company 5.2 %   3.3 %   5.4 %   4.0 %* Excludes impacts from fluctuations of foreign exchange rates. For the quarter, gross profit, as a percentage of sales, was 52.5%, a decrease of 137 basis points versus the prior year. The decrease in gross margin was driven...

Continue reading

Pet Valu Reports Fourth Quarter and Fiscal Year 2025 Results

Grows 2025 Revenue 7%, Adjusted EBITDA(1) 4% and Net Income 12% Raises Quarterly Dividend 8% and Issues 2026 Outlook MARKHAM, Ontario, March 03, 2026 (GLOBE NEWSWIRE) — Pet Valu Holdings Ltd. (“Pet Valu” or the “Company”) (TSX: PET), the leading Canadian specialty retailer of pet food and pet-related supplies, today announced its financial results for the fourth quarter and fiscal year ended January 3, 2026. Fourth Quarter HighlightsSystem-wide sales(2) were $423.7 million, an increase of 9.2% versus Q4 2024. Same-store sales growth(2) was 0.3%. Revenue was $326.4 million, up 10.6% versus Q4 2024. Adjusted EBITDA was $74.6 million, up 9.4% versus Q4 2024, representing 22.9% of revenue. Operating income was $48.1 million, up 0.5% versus Q4 2024. Adjusted Net Income(1) was $34.0 million or $0.49 per diluted share(3), compared to...

Continue reading

Norsk Hydro: Potential impact on Qatalum aluminium production

On March 2, at around 1430 CET, QatarEnergy stopped production of liquefied natural gas (LNG) and associated products. On March 3, at around 1200 CET, QatarEnergy issued a statement that the company is stopping the production of some downstream products in the State of Qatar, including urea, polymers, methanol, aluminium and other products. QatarEnergy supplies gas to Hydro’s joint venture Qatalum. The specific implications for aluminium production at Qatalum are currently unclear and Hydro is seeking to obtain more information. Qatalum is a 50/50 joint venture owned by Hydro and Qatar Aluminum Manufacturing Company Q.P.S.C. (QAMCO). The plant has a nameplate capacity of primary aluminium of 648,000 metric tonnes and casthouse capacity of 687,000 metric tonnes. Qatalum is fully integrated with a smelter, casthouse, carbon plant and a dedicated...

Continue reading

TransUnion Investor Day Scheduled for March 10, 2026

CHICAGO, March 03, 2026 (GLOBE NEWSWIRE) — TransUnion (NYSE: TRU) will host an Investor Day on Tuesday, March 10, 2026. The event, which will begin at 8:00 a.m. Eastern Time (ET) and is expected to conclude at approximately 1:00 p.m. ET, will feature a series of presentations from executive management. Presentation materials and a live webcast of the presentations will be made available on the TransUnion Investor Relations website at http://www.transunion.com/tru. A replay will also be available on the company’s website following the conclusion of the event. About TransUnion (NYSE: TRU) TransUnion is a global information and insights company with over 13,000 associates operating in more than 30 countries. We make trust possible by ensuring each person is reliably represented in the marketplace. We do this with a Tru™ picture...

Continue reading

EXEL Industries: Total number of voting rights and shares at 02.28.2026

EXEL IndustriesA French Société Anonyme with a share capital of €16,969,750Registered office: 54, rue Marcel Paul – 51206 Epernay Cedex – FranceReims Companies Register (RCS): No. 095 550 356  Number of shares and voting rights Article 223-16 of the AMF regulationDate Total number of shares comprising the share capital Total number of voting rightsFebruary 28, 2026   6,787,900   Theoretical voting rights: 9,890,351Exercisable voting rights*: 9,884,340* After deduction of shares without voting rightsAttachmentEXEL Industries Droits de vote 2026.02.28_EN

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.